Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - atorvastatinum - compresse rivestite con film - atorvastatinum 80 mg ut atorvastatinum calcicum trihydricum 86.80 mg, calcii carbonas, cellulosum microcristallinum, lactosum monohydricum 262.44 mg, carmellosum natricum conexum corresp. natrium 6.48 mg, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, e 171, talcum, simeticonum, polysorbatum 65, methylcellulosum, macrogoli 8 stearas typus i, glyceroli monostearas 40-55, xanthani gummi, acidum benzoicum 0.00048 mg, acidum sorbicum, acidum sulfuricum, pro compresso obducto. - riduzione della serumcholesterinkonzentration - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - diltiazemi hydrochloridum - retardtabletten - diltiazemi hydrochloridum 90 mg, lactosum monohydricum max. 256 mg, ricini oleum hydrogenatum, acidum stearicum, carmellosum natricum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 6000, simeticonum, e 171, pro compresso obducto corresp. natrium max. 0.4 mg. - calciumantagonist - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - diltiazemi hydrochloridum - retardtabletten - diltiazemi hydrochloridum 120 mg, lactosum monohydricum max. 216 mg, ricini oleum hydrogenatum, acidum stearicum, carmellosum natricum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 6000, simeticonum, e 171, pro compresso obducto corresp. natrium max. 0.4 mg. - calciumantagonist - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - compresse rivestite con film - gemfibrozilum 450 mg, cellulosum microcristallinum, amylum pregelificatum, silica colloidalis anhydrica, polysorbatum 80, carboxymethylamylum natricum a corresp. natrium 0.34 mg, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - disturbi del metabolismo dei grassi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - compresse rivestite con film - gemfibrozilum 900 mg, silica colloidalis anhydrica, silicii dioxidum praecipitatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.68 mg, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - disturbi del metabolismo dei grassi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - diltiazemi hydrochloridum - retardtabletten - diltiazemi hydrochloridum 180 mg, lactosum monohydricum max. 144 mg, ricini oleum hydrogenatum, acidum stearicum, hydroxyethylcellulosum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 6000, simeticonum, e 171, pro compresso obducto. - calciumantagonist - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - tolterodinum - retard-kapseln - tolterodini tartras 2 mg corresp. tolterodinum 1.37 mg, hypromellosum, sacchari sphaerae corresp. saccharum 40.33 - 59.05 mg et maydis amylum, ethylcellulosum, triglycerida media, acidum oleicum, kapselhülle: gelatina, e 132, e 172 (flavum), e 171, drucktinte: lacca, e 171, propylenglycolum 0.0041 mg, simeticonum, pro capsula. - trattamento della vescica iperattiva - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - tolterodinum - retard-kapseln - tolterodini tartras 4 mg corresp. tolterodinum 2.74 mg, sacchari sphaerae corresp. saccharum 80.66 – 118.10 mg et maydis amylum, hypromellosum, ethylcellulosum, triglycerida media, acidum oleicum, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, e 171, propylenglycolum, simeticonum, pro capsula. - trattamento della vescica iperattiva - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - posaconazolum - sospensione orale - posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, e 171, aromatica (kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg. - infezioni fungine - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

f.i.r.m.a. s.p.a. - miocamicina - miocamicina